Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pittrow

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Clinical Drug Investigation|May 31, 2007
Cardiovascular Parameters during Submaximal Exercise following Submucous Administration of Articaine : A Comparison with Lidocaine and Placebo in Young Healthy VolunteersD Pittrow, C Schindler, U Maywald, et al.
Deutsche Medizinische Wochenschrift (1946)|March 12, 2010
[Clinical pharmacology and electrophysiological properties of dronedarone]T Lewalter, D Pittrow, A Goette, et al.
MMW Fortschritte Der Medizin|October 31, 2003
[Risk of vascular occlusion in your patient? With the ankle-arm index general practitioners discover the risk much earlier]C Diehm, H J Trampisch, B von Stritzky, et al.
European Journal of Clinical Investigation|April 2, 2009
Bleeding events in pulmonary arterial hypertensionC F Opitz, W Kirch, E A Mueller, et al.
Deutsche Medizinische Wochenschrift (1946)|May 31, 2013
[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation]H Kaemmerer, M Gorenflo, M Hoeper, et al.
Addiction (Abingdon, England)|October 2, 2003
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological dataG Hajak, W E Müller, H U Wittchen, et al.
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)]D Pittrow, H A Ghofrani, C F Opitz, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2012
[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry]J Behr, M M Hoeper, M Kreuter, et al.
Pharmacopsychiatry|July 25, 2008
The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteersT Siepmann, M Mueck-Weymann, R Oertel, et al.
International Journal of Clinical Practice|February 27, 2013
Extended-release niacin/laropiprant for lipid management: observational study in clinical practiceE Steinhagen-Thiessen, W Dänschel, C Buffleben, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Clinical Drug Investigation|May 31, 2007
Cardiovascular Parameters during Submaximal Exercise following Submucous Administration of Articaine : A Comparison with Lidocaine and Placebo in Young Healthy VolunteersD Pittrow, C Schindler, U Maywald, et al.
Deutsche Medizinische Wochenschrift (1946)|March 12, 2010
[Clinical pharmacology and electrophysiological properties of dronedarone]T Lewalter, D Pittrow, A Goette, et al.
MMW Fortschritte Der Medizin|October 31, 2003
[Risk of vascular occlusion in your patient? With the ankle-arm index general practitioners discover the risk much earlier]C Diehm, H J Trampisch, B von Stritzky, et al.
European Journal of Clinical Investigation|April 2, 2009
Bleeding events in pulmonary arterial hypertensionC F Opitz, W Kirch, E A Mueller, et al.
Deutsche Medizinische Wochenschrift (1946)|May 31, 2013
[Pulmonary arterial hypertension in patients with congenital heart disease: current issues and health care situation]H Kaemmerer, M Gorenflo, M Hoeper, et al.
Addiction (Abingdon, England)|October 2, 2003
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological dataG Hajak, W E Müller, H U Wittchen, et al.
Deutsche Medizinische Wochenschrift (1946)|September 1, 2009
[International, prospective register for the documentation of first-line and maintenance therapy in patients with pulmonary hypertension (CompERA-XL)]D Pittrow, H A Ghofrani, C F Opitz, et al.
Deutsche Medizinische Wochenschrift (1946)|November 29, 2012
[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry]J Behr, M M Hoeper, M Kreuter, et al.
Pharmacopsychiatry|July 25, 2008
The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteersT Siepmann, M Mueck-Weymann, R Oertel, et al.
International Journal of Clinical Practice|February 27, 2013
Extended-release niacin/laropiprant for lipid management: observational study in clinical practiceE Steinhagen-Thiessen, W Dänschel, C Buffleben, et al.
Pageof 8